You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華邦健康(002004.SZ):擬出售穎泰生物12.31%股份 引入戰略投資者新安股份
格隆匯 09-03 16:39

格隆匯9月3日丨華邦健康(002004.SZ)公佈,2021年6月9日,公司與浙江新安化工集團股份有限公司(“新安股份”)、北京穎泰嘉和生物科技股份有限公司(“穎泰生物”)簽訂了《戰略合作協議》。各方為進一步推動業務共同發展,致力於以穎泰生物作為合作平台,在農化、轉基因領域的產品佈局、產業鏈拓展、市場及渠道協同等方面建立全面、深入的戰略合作伙伴關係,達成合作意向。

2021年9月3日,公司與新安股份簽訂《股份轉讓協議》,轉讓公司持有的穎泰生物1.5095億股股份(“標的股份”),佔穎泰生物股本總額12.31%,新安股份以自有資金受讓標的股份。交易價格結合評估公司出具的評估報吿及穎泰生物近期實施的分紅方案確認為5.30元/股,總轉讓款為人民幣8.00億元。

此次股份轉讓完成後,華邦健康直接持有穎泰生物652,113,154股股份,公司全資子公司卓遠匯醫投資有限公司持有穎泰生物15,242,500股股份,公司及全資子公司合計持有667,355,654股,合計持股比例為54.44%,仍為穎泰生物的控股股東。

公司通過降低穎泰生物的持股比例,引入戰略投資者,有助於穎泰生物與新安股份優勢互補,促進雙方在技術研發、生產基地、市場渠道、產業鏈管理等方面協同,進一步優化產品和產業佈局,提升穎泰生物核心競爭力。

轉讓完成後,公司持有穎泰生物的股份比例由現有的66.76%降低為54.44%,華邦健康仍擁有穎泰生物控制權,穎泰生物仍在公司合併報表範圍內。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account